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Abstract. 
 
Cell migration and wound contraction re-
quires assembly of actin into a functional myosin motor 
unit capable of generating force. However, cell migra-
tion also involves formation of actin-containing mem-
brane rufﬂes. Evidence is provided that actin-myosin 
assembly and membrane rufﬂing are regulated by dis-
tinct signaling pathways in the migratory cell. Interac-
tion of cells with extracellular matrix proteins or cyto-
kines promote cell migration through activation of the 
MAP kinases ERK1 and ERK2 as well as the molec-
ular coupling of the adaptor proteins p130CAS and
c-CrkII. ERK signaling is independent of CAS/Crk 
coupling and regulates myosin light chain phosphoryla-
tion leading to actin-myosin assembly during cell mi-
gration and cell-mediated contraction of a collagen
matrix. In contrast, membrane rufﬂing, but not cell con-
traction, requires Rac GTPase activity and the forma-
tion of a CAS/Crk complex that functions in the con-
text of the Rac activating protein DOCK180. Thus, 
during cell migration ERK and CAS/Crk coupling op-
erate as components of distinct signaling pathways that 
control actin assembly into myosin motors and mem-
brane rufﬂes, respectively.
Key words: adaptor proteins • cell migration • mito-
gen-activated protein kinase • myosin • signal trans-
duction
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 development, wound repair and inflamma-
tion cells migrate in response to growth factors/
cytokines and adhesive proteins present in the ex-
 
tracellular matrix (ECM)
 
1
 
 (Lauffenburger and Horwitz,
1996; Keely et al., 1998). In many cases, these events are
mediated by cytokine and integrin receptors that transmit
a cascade of signals important for regulation of the migra-
tion machinery (Lauffenburger and Horwitz, 1996; Aplin
et al., 1998; Keely et al., 1998). Initiation of migration is
characterized by the rapid reorganization of actin to the
cell edge. This results in the protrusion of a leading lamel-
lipodium with new adhesive contacts necessary for trac-
tion. Membrane ruffles are often found on the cell surface
and at the advancing front of a lamellipodium. They are
thought to serve as sites of actin polymerization, endocyto-
sis, receptor tyrosine kinase signaling, and protease activ-
ity (Lauffenburger and Horwitz, 1996; Mitchison and
Cramer, 1996). However, for a cell to move, it must also
organize actin into a functional actin-myosin motor unit
capable of generating contractile force. This propels the
cell forward and contributes to the release of adhesive
contacts at the rear of the cell (Lauffenburger and Hor-
witz, 1996; Mitchison and Cramer, 1996). Myosin II is the
best-characterized myosin isoform and is well known to
promote contraction in non-muscle cells (Kolega et al.,
1993; Jay et al., 1995). The ability of myosin II to associate
with actin and mediate contraction are modulated by the
 
phosphorylation of the regulatory light chain by the Ca
 
2
 
1
 
/
calmodulin-dependent enzyme myosin light chain kinase
(MLCK) as well as dephosphorylation by myosin phos-
phatase (Adelstein, 1983; Yoshioka et al., 1998).
While significant progress has been made in identifying
biochemical signals involved in cell migration, the rela-
tionship of these events and how they impact the migra-
tion machinery of cells are not well defined. Given the
complexity of cell motility, it is not surprising that multiple
signals regulate this process. Indeed, PLC
 
g
 
 (Chen et al.,
1994), FAK (Ilic et al., 1995; Parsons, 1996; Cary and
Guan, 1998), c-Src (Rodier et al., 1995; Boyer et al., 1997;
Fincham and Frame, 1998), PI3 kinase (Keely et al., 1997),
MAP kinase (Anand-Apte et al., 1997; Klemke et al.,
1997; Wei et al., 1998), as well as Tiam1 (Michiels et al.,
1995; Sander et al., 1998) and the Rho family of small
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GTPases have all been shown to modulate cell migration
(Keely et al., 1997, 1998; Tapon and Hall, 1997).
Recently, the adaptor proteins p130CAS (CAS) and
c-CrkII (Crk) have been shown to be involved in cell mi-
gration (Cary et al., 1998; Klemke et al., 1998). Adaptor
proteins (Nck, Crk, Shc, Grb2) do not contain catalytic ac-
tivity but consist primarily of src homology 2 (SH2) and 3
(SH3) domains that serve to assemble signal generating
complexes and target them to discrete sites within the cell
(Bar-Sagi et al., 1993). For example, activation of cytokine
and integrin receptors promotes tyrosine phosphorylation
of the substrate domain of CAS and its association with
the SH2 domain of Crk (Vuori et al., 1996; Casamassima
and Rozengurt, 1997, 1998; Ojaniemi and Vuori, 1997).
Crk, in turn, binds though its SH3 domain to several
downstream effector molecules including the small GTP-
ase activating proteins DOCK180, C3G, and SOS (Mat-
suda et al., 1994; Feller et al., 1995; Hasegawa et al., 1996).
While the coupling of CAS to Crk can serve as a “molec-
ular switch” leading to cell migration and metastasis
(Klemke et al., 1998), it is not yet known how these pro-
teins impact the migration machinery of cells. That CAS
and Crk localize to focal contacts as well as membrane ruf-
fles suggest this protein complex may regulate these pro-
cesses in migratory cells. However, CAS and Crk may also
facilitate cell migration through its ability to couple to
NCK and/or SOS which is known to facilitate activation of
the Ras/ERK pathway (Schlaepfer et al., 1997). Activated
ERK can modulate integrin affinity and phosphorylate
myosin light chain kinase leading to increased MLC phos-
phorylation (Hughes et al., 1997; Klemke et al., 1997).
Both of these signaling events may be important for cell
migration as MLC phosphorylation facilitates contraction
and remodeling of adhesive structures (Adelstein, 1983;
Lauffenburger and Horwitz, 1996; Chrzanowska-Wod-
nicka and Burridge, 1996; Mitchison and Cramer, 1996;
Rosenfeldt et al., 1998). Furthermore, cell contraction and
integrin aggregation can lead to activation of FAK (Chrza-
nowska-Wodnicka and Burridge, 1996). Since FAK and/or
c-src that associates with FAK can tyrosine phosphorylate
CAS, this could also facilitate CAS/Crk complexes and
Rac activation (Vuori et al., 1996; Tachibana et al., 1997).
Thus, it is feasible that CAS/Crk and ERK may cooperate
to promote both actin-myosin function and membrane ruf-
fling in migratory cells. In fact, v-Crk has recently been
shown to promote activation of Rho which can facilitate
MLC phosphorylation and migration (Altun-Gultekin et
al., 1998; Yoshioka et al., 1998). Alternatively, these events
may not be coupled, but represent separate biochemical
pathways capable of regulating these cellular processes.
In this report, we investigate whether CAS/Crk coupling
and ERK activation are the same or parallel signaling
pathways involved in the regulation of actin assembly into
membrane ruffles as well as myosin motors. Evidence is
provided that CAS/Crk coupling regulates the migration
machinery by promoting membrane ruffling independent
of ERK signaling. In contrast, ERK, but not CAS/Crk,
controls MLC phosphorylation leading to actin/myosin-
mediated cell contraction. These findings suggest that dur-
ing cell migration CAS/Crk and ERK signaling operate as
distinct biochemical pathways necessary for membrane
ruffling and cell contraction, respectively.
 
Materials and Methods
 
Expression Vectors and Reagents
 
The expression plasmid pUCCAGGS containing either full-length
DOCK180, myc-tagged c-CrkII, c-CrkII cDNA with a mutated amino-ter-
minal SH3 domain (tryptophan 109 to cysteine), or Crk with a mutated
SH2 domain (arginine 38 to valine) have been previously described (Mat-
suda et al., 1993, 1994; Tanaka et al., 1993; Kiyokawa et al., 1998b). The
pEBG expression plasmid containing glutathione-
 
S
 
-transferase–tagged or
untagged wild-type p130CAS or CAS with an in frame deletion of its sub-
strate domain (CAS-SD, amino acids 213–514) have been previously de-
scribed (Mayer et al., 1995). Myc-tagged dominant negative Rac 1 (N17)
and mutationally activated MEK in pcDNA3 has been previously
described (Minden et al., 1995; Klemke et al., 1997). PD98059 (2-[2
 
9
 
-
amino-3
 
9
 
methoxyphenyl]-oxanaphthalen-4-one; Calbiochem-Novobiochem).
Anti-myosin antibody that recognizes the myosin IIB isoform present in
COS7 cells was a gift from Dr. Robert Adelstein (Molecular Cardiology,
National Lung Heart and Lung Institute, National Institutes of Health,
Bethesda, MD). The phosphoERK antibody was from Promega. The anti-
Rac, DOCK180, and myc antibodies were from Santa Cruz Biotechnol-
ogy. FG-C are human pancreatic carcinoma cells stably overexpressing
c-CrkII as previously described (Klemke et al., 1998).
 
Transfection of COS-7 and Analysis of Cell Migration
 
Transient transfection of COS cells and Transwell migration assays were
performed as previously described (Klemke et al., 1998). In brief, COS-7
cells were cotransfected with lipofectamine and expression vectors con-
taining cDNAs encoding wild-type and/or mutant forms of MEK, Crk or
CAS, Rac, DOCK180, along with a reporter construct encoding 
 
b
 
-galac-
tosidase (pCMV5-
 
b
 
-gal) or green fluorescent protein (pEGFP-C1; Clon-
tech). Control cells were mock-transfected with the appropriate amount
of the empty expression vectors along with the 
 
b
 
-gal reporter. Cells were
allowed to incorporate the cDNA constructs for 6–8 h, washed, and then
allowed to incubate for 40 h which provides optimal transient expression
in these cells. COS cells were then prepared for haptotaxis cell migration
using X-gal as a substrate and analyzed for expression of specific proteins
by immunoprecipitation and immunoblotting as previously described
(Klemke et al., 1998). Transfection efficiency and cell adhesion of these
cells to purified extracellular matrix proteins were monitored as described
below. The migration of FG cells, metabolic labeling of transfected cells
with [
 
32
 
P]orthophosphate, immunoprecipitation of myosin light chains,
SDS-PAGE, and autoradiography were performed as previously described
(Klemke et al., 1997).
 
Cell Adhesion and Transfection Efficiency
 
Controls for transfection efficiency and cell adhesion to ECM proteins
were performed as previously described (Klemke et al., 1998). In brief, an
aliquot of cells from the migration experiments above was allowed to at-
tach to culture dishes coated with purified ECM proteins. The dishes were
washed and adherent cells transfected with the 
 
b
 
-gal reporter gene were
detected using X-gal as a substrate according to the manufacturer’s rec-
ommendation (Promega). In typical transfection experiments with these
cells, we obtain 70–75% efficiency, as determined by counting the number
of 
 
b
 
-gal positive cells relative to the total number of cells attached per
field (200
 
3
 
). It is important to note that in an individual experiment,
transfection efficiently varies 
 
,
 
10%. The efficiency and adhesion control
assures that changes observed in cell migration is not simply the result of
differences in transfection efficiency or expression of the 
 
b
 
-gal reporter
gene or differences in the ability of transfected cells to attach to the ECM.
 
Laser Confocal Imaging of Membrane Ruffles, Actin, 
and Myosin IIB
 
COS-7 cells were cultured on glass coverslips and then transfected as
described above along with a reporter construct encoding either GFP or
 
b
 
-gal. Cells were serum-starved for 24 h then treated with or without insu-
lin (10 
 
m
 
g/ml) or IGF-1 (20 ng/ml) for 15 min. In some cases, MEK or
mock-transfected cells were exposed to 50 
 
m
 
M PD98059 for 2 h before be-
ing treated with insulin or IGF-1 as described above. To visualize F-actin
containing membrane ruffles, cells were rinsed in PBS then fixed in 4%
paraformaldehyde, permeabilized with 0.2% Triton X-100, and stained
with rhodamine-conjugated phalloidin. Cells with prominent actin-rich 
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membrane ruffles were quantified blindly by two independent investiga-
tors and represents the average number of transfected cells (i.e., GFP
cells) with ruffles of eight high powered fields (400
 
3
 
). To observe F-actin
filaments and myosin IIB colocalization in cells, we used a procedure that
preserves the association of these proteins in whole cells. In brief, cells
were extracted with 0.1% Triton X-100 detergent, fixed in 4% parafor-
maldehyde, then stained with rhodamine-conjugate phalloidin and rabbit
anti-myosin IIB, followed by FITC-conjugated secondary antibodies as
previously described (Cramer and Mitchison, 1995). In some cases, cells
transfected with the 
 
b
 
-gal reporter construct were detected by staining
with mouse anti-
 
b
 
-gal and donkey anti-Cy5-conjugated secondary anti-
bodies along with three color cell fluorescence and a laser confocal micro-
scope (Bio-Rad 1024 and a Zeiss axiovert microscope). Myosin content
per cell was obtained by determining the fluorescence intensity (sum of
total green pixels 
 
3
 
 intensity) in the green/FITC channel per cell area
(
 
m
 
m
 
2
 
) using Adobe Photoshop and IPLab Spectrum
 
 
 
P
 
 
 
computer software.
 
Cell Contraction of Collagen Gels
 
Cell contraction of a three-dimensional collagen matrix was performed as
previously described (Rosenfeldt et al., 1998). In brief, 1 
 
3 
 
10
 
6
 
 cells/ml
collagen were cultured for 2 d in DME containing 10% FBS. Cells were
serum-starved for 4 h then exposed for 60 min to serum-free culture media
containing PD98059 (50 
 
m
 
M), M7 (1 
 
m
 
M; [(5-iodonaphthalene-1-sulfo-
nyl)homopiperazine, HCL; Calbiochem-Novabiochem], or BDM (10 mM;
butanedione monoxime; Sigma Chemical Co.). To initiate contraction,
collagen gels were mechanically released from the culture dish in the con-
tinued presence of the inhibitors. The change in diameter in millimeters
was measured with a ruler at various times after release. In some cases,
cells were washed to remove the inhibitors then cultured an additional 24 h
in drug-free media before initiation of contraction as described above.
 
Results
 
CAS/Crk Coupling and ERK Activation Represent 
Distinct Signals Necessary for Cell Migration
 
Recently, we reported that CAS/Crk coupling as well as
ERK activation facilitate cell migration (Klemke et al.,
1997, 1998). Each of these events were shown to be re-
quired for cell migration, yet it remains unclear whether
these signals represent the same or parallel pathways in-
volved in regulation of this process. To address this issue,
cells were transfected with CAS lacking its substrate
domain (CAS-SD) or Crk with a mutated SH2 domain
(CRK-SH2), either of which are capable of preventing
CAS/Crk coupling and downstream signaling events (Fel-
ler et al., 1994; Matsuda et al., 1994; Klemke et al., 1998).
Cells containing these cDNAs were treated with the cy-
tokine insulin and examined for migration as well as
ERK activity. Expression of either CAS-SD or Crk-SH2
blocked insulin-induced cell migration, yet had no effect
on ERK activity in these cells (Fig. 1 A). Similar findings
were observed in cells expressing Crk with a mutated
amino-terminal SH3 domain that retains its ability to cou-
ple to CAS, but is unable to link to downstream effector
molecules such as DOCK180 or C3G (data not shown;
Matsuda et al., 1994; Kiyokawa et al., 1998a,b). These find-
ings reveal that disruption of CAS/Crk coupling or its
binding to downstream effectors can suppress cell migra-
tion without influencing ERK activity.
To determine whether ERK signaling represents an in-
dependent pathway necessary for cell migration, cells were
induced to migrate with insulin and then exposed to the
compound PD98059 that blocks ERK kinase (MEK), and
thereby prevents ERK activation (Dudley et al., 1995).
These cells were then examined for cell migration, ERK
Figure 1. ERK activation and CAS/Crk coupling are separate
signaling events necessary for cytokine-induced cell migration.
(A) Serum-starved COS-7 cells were allowed to migrate for 3 h
on vitronectin-coated membranes in the presence or absence of
insulin (10 mg/ml) after transient transfection with a b-gal re-
porter construct, along with either the empty expression vector
(Mock) or with expression vectors encoding gst-tagged CAS
without its substrate domain (CAS-SD), or myc-tagged Crk with
a mutated SH2 domain (Crk-SH2). CAS-SD and Crk-SH2 have
been shown to prevent CAS/Crk coupling and downstream sig-
nals (Matsuda et al., 1993; Feller et al., 1994; Klemke et al., 1998).
The number of transfected cells migrating were enumerated by
counting cells on the underside of the membrane that coexpress
the b-gal vector as described in Materials and Methods. An ali-
quot of cells treated as described for the migration experiment
above was lysed in detergent and immunoblotted with antibodies
to either the phosphorylated/activated form of ERK1/ERK2
(lower panel), Crk, or CAS (top right). Note that Crk-SH2 shows
reduced mobility compared with wild-type endogenous Crk
(Crk-WT) as the result of the molecular tag. (B) Serum-starved
COS-7 cells were allowed to migrate in the presence or absence
of the MEK inhibitor PD98059 (25 mM) with or without insulin
(10 mg/ml). Cell migration and ERK1/ERK2 activity in these
cells were determined as described above. Similar findings were
obtained with fibronectin and collagen type I–coated membranes
(data not shown). Each bar represents the mean 6 SEM of at
least three independent experiments. (C) Serum-starved COS-7
cells pretreated with or without the MEK inhibitor PD98059 (50
mM) for 2 h were exposed to insulin (10 mg/ml) for 5 min before
being lysed in detergent. CAS was immunoprecipitated and then
immunoblotted with antibodies to either phosphotyrosine, Crk,
or CAS. The detergent lysates from these cells were also exam-
ined for changes in ERK1/ERK2 activity as described above. The
result shown is representative from at least three independent ex-
periments. 
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activity, and formation of CAS/Crk complexes. While the
MEK inhibitor prevented insulin-induced cell migration
and ERK1/ERK2 activation, it did not impact CAS ty-
rosine phosphorylation or the formation of CAS/Crk com-
plexes in these cells (Fig. 1, B and C). Similar findings
were observed when cells were stimulated to migrate with
either EGF or IGF-1 (data not shown). Thus, CAS/Crk
coupling and ERK activation appear to represent compo-
nents of distinct signaling pathways necessary for cyto-
kine-induced cell migration.
To investigate directly whether formation of a CAS/Crk
complex could activate ERK, serum-starved COS-7 cells
were transiently transfected with vectors encoding CAS
and Crk or mutationally activated MEK. These cells were
then examined for ERK activity and migration. Expres-
sion of MEK in these cells promoted a four- to fivefold in-
crease in cell migration and significantly increased ERK
activity compared with mock-transfected control cells
(Fig. 2 A). However, while CAS/Crk transfected cells
showed a fourfold increase in cell migration, there was no
change in ERK activity (Fig. 2 A). Similar findings were
obtained in FG carcinoma cells stably transfected with c-Crk
(FG-C). These cells also showed significantly enhanced
migration, yet ERK activity was the same as control cells
(Fig. 2, B and C). Together, these findings indicate that
CAS/Crk-induced cell migration does not result from in-
creased ERK activity. However, since ERK signaling ap-
peared to be a separate event necessary for cell migration,
we investigated whether ERK activity was also necessary
for CAS/Crk-induced cell movement. To investigate this
possibility, FG-C and COS-7 cells transfected with CAS
and Crk were exposed to PD98059 and analyzed for their
ability to migrate on ECM proteins. In this case, PD98059
blocked cell migration induced by CAS/Crk (Fig. 2, A and
B) without affecting the formation of CAS/Crk complexes
in these cells (data not shown). Conversely, MEK-induced
cell migration was blocked by expression of CAS-SD or
dominant negative RacN17 (Fig. 3, A and B) without im-
pacting ERK activity (data not shown). Thus, CAS/Crk/
Rac signaling and ERK activation appear to be separate
biochemical pathways necessary for cell migration.
 
Membrane Ruffling Requires CAS/Crk and Rac, but 
Not ERK Activity
 
Activation of cell migration is characterized by the assem-
bly of actin into membrane ruffles as well as cell contrac-
tion (Lauffenburger and Horwitz, 1996; Mitchison and
Cramer, 1996). To explain how the coupling of CAS/Crk
and activation of ERK might influence the migration ma-
chinery, cells expressing CAS-SD were stimulated with in-
sulin and then examined for actin-containing membrane
Figure 2. CAS/Crk-induced
cell migration does not result
from increased ERK activity.
(A) Upper panel, serum-
starved COS-7 cells were al-
lowed to migrate for 3 h in
the presence or absence of
the MEK inhibitor PD98059
(25  mM) on vitronectin-
coated membranes after tran-
sient transfection with a b-gal
reporter construct, along with
either the empty expression
vector or with expression vec-
tors encoding gst-tagged wild-
type CAS and myc-tagged
c-Crk or mutationally acti-
vated MEK. The number of
transfected cells migrating
was enumerated by counting
cells on the underside of the
membrane that coexpress the
b-gal vector as described in
Materials and Methods. Each
bar represents the mean 6 SEM of at least three independent experiments. Lower panels, total cell lysates prepared from cells treated
as described for the migration experiments above were immunoblotted with antibodies that recognize the activated form of ERK1/
ERK2 proteins, Crk, or CAS. Note that the gstCAS and myc-Crk proteins show reduced mobility compared with endogenous wild-type
forms of these proteins as the result of the molecular tags. Immunoblots were exposed to film for 15 and 90 s after treatment with en-
hanced chemiluminescence reagents as described in Materials and Methods. (B) Serum-starved FG cells stably transfected with Crk or
mock-transfected with the empty vector were allowed to migrate on vitronectin or collagen-coated membranes for 3 h in the presence
or absence of PD98059 (25 mM) and quantified as described in Materials and Methods. Each bar represents the mean 6 SEM of at least
three independent experiments. (C) Cells treated as described for the migration experiment above were either held in suspension (SUS)
or allowed to attach (ATT) to collagen-coated culture dishes for 30 min, then lysed in detergent and immunoblotted with either anti-
bodies that specifically recognize the activated form of ERK1/ERK2 proteins (upper panel), ERK2 (middle panel), or Crk (lower
panel). The upper band recognized by the ERK2 antibody represents the phosphorylated/activated form of this protein (ERK2-P) that
has reduced mobility as a result of being phosphorylated. Similar results were obtained with ERK1 protein (data not shown). 
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ruffles. Exposure of mock-transfected control cells to insu-
lin induced prominent membrane ruffles rich in F-actin
(Fig. 4 A). Approximately 18% of the control cell popula-
tion showed membrane ruffling before stimulation with in-
sulin and this was increased to 80% after cells were ex-
posed to this cytokine (Fig. 4 B). Importantly, expression
 
of CAS-SD in these cells completely blocked the insulin-
induced membrane ruffling response (Fig. 4, A and B). As
expected, cells within the field of view not transfected with
CAS-SD showed prominent membrane ruffles (Fig. 4 A).
Expression of Crk-SH2 in cells also blocked insulin-
induced membrane ruffles (data not shown). Recently, it
was reported that CAS/Crk coupling facilitates Rac activ-
ity which can promote membrane ruffling (Ridely et al.,
1992; Kiyokawa et al., 1998a). Therefore, we determined
whether CAS/Crk-induced membrane ruffles required Rac
activity. Cells were transfected with CAS and Crk along
with a dominant negative form of Rac (RacN17) and then
examined for F-actin containing membrane ruffles. Ex-
pression of RacN17 in these cells blocked CAS/Crk-
induced ruffles (Fig. 4 C). RacN17 also blocked cell migra-
tion without impacting ERK activity (data not shown).
Thus, CAS/Crk coupling promotes membrane ruffles that
depend on Rac, but not on ERK activity.
 
DOCK180 Potentiates CAS/Crk-mediated
Cell Migration
 
Crk is known to bind to a number of downstream effector
molecules via its SH3 domain, including c-Abl, SOS, C3G,
Eps15, and DOCK180 (Matsuda et al., 1994; Feller et al.,
1995; Hasegawa et al., 1996). Among these Crk-binding
proteins, DOCK180 has been associated with Rac activa-
tion (Kiyokawa et al., 1998a). Moreover, in 
 
Caenorhabdi-
tis elegans 
 
and 
 
Drosophila melanogaster
 
, the DOCK180
homologue ced-5 and mbc, respectively, control cell mi-
gration events associated with development (Erickson et
al., 1997; Wu and Horvitz, 1998). Therefore, we were
prompted to investigate the role of DOCK180 in cell mi-
gration. As shown in Fig. 4, D and E, expression of
DOCK180 was able to potentiate CAS/Crk-induced cell
migration in a Rac-dependent manner, yet it had no effect
on ERK activity in these cells. Together these findings
suggest that CAS/Crk in conjunction with DOCK180 can
form a signaling module involved in Rac-mediated mem-
brane ruffling and cell movement that is independent of
ERK activation.
To investigate the role of ERK-dependent signaling in
actin assembly, cells exposed to the cytokine insulin were
treated in the presence or absence of the MEK inhibitor,
PD98059. This inhibitor, which blocks cell migration, but
not adhesion or spreading on collagen or vitronectin sub-
strates (Fig. 1 B), failed to disrupt membrane ruffling in
response to insulin (Fig. 4 A). In fact, 70% of cells exposed
to PD98059 and insulin showed membrane ruffling, com-
pared with 80% of cells exposed to insulin alone (Fig. 4 B).
Together these findings indicate that CAS/Crk coupling is
necessary for membrane ruffling, whereas ERK activity
is not.
 
ERK Activity, but Not CAS/Crk Coupling, Is Necessary 
for Actin-myosin Assembly and Cell Contraction of a 
Three-dimensional Collagen Matrix
 
Cell migration also involves myosin light chain phosphoryla-
tion leading to actin-myosin association and cell contrac-
tion. While ERK can phosphorylate MLCK leading to in-
creased MLC phosphorylation, it is not yet known if this
event promotes assembly of a functional actin-myosin mo-
Figure 3. ERK-induced cell migration requires CAS/Crk and
Rac activity. (A) Upper panel, serum-starved COS-7 cells were
allowed to migrate for 3 h on vitronectin-coated membranes after
transient transfection with a b-gal reporter construct, along with
either the empty expression vector or with expression vectors en-
coding mutationally activated MEK, or MEK cotransfected with
dominant negative CAS (CAS-SD). The number of transfected
cells migrating were enumerated by counting cells on the under-
side of the membrane that coexpress the b-gal vector as described
in Materials and Methods. Each bar represents the mean 6 SEM
of at least three independent experiments. Lower panels, cells
treated as described for the migration experiment above were
lysed in detergent and immunoblotted with antibodies to the acti-
vated form of ERK1/ERK2 (middle panel) or ERK2 (lower
panel). The upper band recognized by the ERK2 antibody re-
presents the phosphorylated/activated form of this protein
(ERK2-P) that has reduced mobility as a result of being phos-
phorylated. Similar results were obtained with ERK1 protein
(data not shown). (B) Serum-starved COS-7 cells were allowed
to migrate for 3 h on vitronectin-coated membranes after tran-
sient transfection with a b-gal reporter construct, along with ei-
ther the empty expression vector or with expression vectors en-
coding mutationally activated MEK, or MEK together with
dominant negative myc-tagged Rac (RacN17) in the presence or
absence of insulin (10 mg/ml) in the lower chamber. An aliquot of
cells transfected with RacN17 and lysed and immunoblotted with
an antibody to Rac is shown (top right). Note that RacN17 mi-
grates slower as the result of the myc tag compared with endoge-
nous wild-type Rac (Rac-Wt). Each bar represents the mean 6
SEM of at least three independent experiments. 
The Journal of Cell Biology, Volume 146, 1999 1112
 
tor capable of generating force necessary for cell contrac-
tion (Klemke et al., 1998). This, and the fact that ERK did
not influence membrane ruffling, yet appeared critical for
cell migration, prompted us to examine its role in actin-
myosin assembly and contractile function. We also investi-
gated the role of CAS and Crk in this process since it is not
known if these proteins regulate actin-myosin activity in-
dependent of their ability to organize actin into membrane
ruffles. Cells were stimulated with insulin or transfected
with mutationally activated MEK and examined for phos-
phorylation of MLC, which facilitates actin-myosin bind-
ing and motor activity (Adelstein, 1983). These cells were
also examined for actin-myosin colocalization by immuno-
fluorescent staining and laser confocal microscopy. Cells
Figure 4. CAS/Crk associa-
tion, but not ERK activation,
is required for Rac-depen-
dent membrane ruffling. (A)
Serum-starved COS-7 cells in
the presence or absence of
insulin (10 mg/ml for 15 min)
were stained with rho-
damine-conjugated phalloi-
din, then analyzed by confo-
cal imaging for F-actin (red)
containing membrane ruffles
after being transfected with
either the empty vector (con-
trol) or the vector encoding
dominant negative CAS
(CAS-SD) along with a re-
porter vector encoding green
fluorescent protein (GFP) to
identify transfected cells. In
some cases, control cells
were pretreated for 2 h with
50 mM of PD98059 to inhibit
ERK activity before being
exposed to insulin as de-
scribed above. Photomicro-
graphs were taken with a
Bio-Rad Labs 1024 laser and
a Zeiss Axiovert microscope
(4003). Arrowheads indicate
cells with prominent F-actin
membrane ruffles. (B) COS-7
cells treated as described
above were scored for mem-
brane ruffles as described in
Materials and Methods. Re-
sults are expressed as the
percentage of total trans-
fected cells (i.e., green cells)
that displayed prominent
F-actin membrane ruffles
and are the mean 6 SEM of
three separate experiments.
(C) COS cells were trans-
fected with expression vec-
tors encoding CAS, Crk, and dominant negative RacN17, along with a reporter vector encoding GFP, then examined for actin mem-
brane ruffles as describe above. Photomicrographs of CAS/Crk cells (4003) and RacN17 expressing cells (6003) were taken with a
Bio-Rad Labs 1024 laser and a Zeiss Axiovert microscope. Arrowheads indicate cells with prominent F-actin membrane ruffles. (D)
COS-7 cells transfected with either wild-type DOCK180, gst-tagged CAS and myc-tagged Crk, or CAS and Crk, together with
DOCK180 and/or myc-tagged RacN17 were examined for cell migration as described above. An aliquot of cells transfected with CAS/
Crk and DOCK180 (lane 2) or cells mock-transfected with the empty vectors (lane 1) as described for the migration experiment above
were lysed in detergent and immunoblotted with antibodies to the phosphorylated/activated form of ERK1/ERK2 as described above
(top left). Note that in these experiments cells were transfected with CAS/Crk vectors at DNA levels that give half-maximal migration.
Each bar represents the mean 6 SEM of at least three independent experiments. (E) An aliquot of cells treated as for the migration ex-
periment above were lysed in detergent then immunoblotted with antibodies to CAS, Crk, DOCK180, or myc to detect myc-tagged
RacN17. Lane 1, control cells transfected with the empty vectors. Lane 2, cells transfected with the vector containing the cDNA as indi-
cated. Note that the gstCAS and mycCrk proteins show reduced mobility compared with endogenous wild-type forms of these proteins
as the result of the molecular tag. Bars, 10 mm. 
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exposed to insulin or those expressing MEK
 
1
 
 showed
increased phosphate incorporation into MLC compared
with unstimulated or mock-transfected control cells (Fig. 5
A). Exposure to insulin or transfection with MEK also
promoted increased actin-myosin colocalization compared
with control cells (Fig. 5, B and C). In fact, the amount of
insoluble myosin associated with these cells after extrac-
tion in detergent was increased by two- to threefold (Fig. 5
D). Importantly, PD98059 blocked insulin and MEK-
induced MLC phosphorylation as well as actin-myosin
colocalization, indicating that ERK activity was required
for this response (Fig. 5, A–D). In contrast, transfection of
cells with CAS-SD, which blocks membrane ruffling (Fig.
4), failed to block MLC phosphorylation and actin-myosin
colocalization in response to insulin or expression of
MEK
 
1
 
 (Fig. 5, A–D). Therefore, ERK activation selec-
tively promotes MLC phosphorylation and actin-myosin co-
localization, whereas CAS/Crk coupling facilitates mem-
brane ruffling.
While cells require actin-myosin motor function for mo-
tility, these same events generate mechanical force neces-
sary for wound contraction (Grinnell, 1994). Therefore,
we investigated the role of ERK and CAS/Crk coupling in
cell-mediated contraction of the extracellular matrix. Cells
were transfected with CAS-SD or exposed to PD98059
and then examined for their ability to contract a three-
dimensional collagen matrix. Exposure of cells to the
MEK inhibitor significantly reduced the rate of cell con-
Figure 5. ERK, but not
CAS/Crk signaling, pro-
motes myosin light chain
phosphorylation and actin-
myosin colocalization. (A)
Myosin light chains (MLC)
immunoprecipitated with an
anti-myosin IIB antibody
from COS-7 cells metaboli-
cally labeled with [32P]ortho-
phosphate and treated with
or without insulin (10 mg/ml)
for 5 min as described in Ma-
terials and Methods. In some
cases,  32P-labeled cells were
pretreated for 2 h with or
without the MEK inhibitor
PD98059 or transfected with
mutationally activated MEK,
and/or CAS-SD before im-
munoprecipitation of myo-
sin IIB and SDS-PAGE as
described above. MLC-P de-
notes phosphorylated light
chain. MLC shows light
chains stained with Coo-
massie before autoradiogra-
phy to confirm that equal
amounts of protein were pre-
cipitated in these experi-
ments. (B) Serum-starved
COS-7 cells either pretreated
with the MEK inhibitor
PD98059 (25 mM) or trans-
fected with CAS-SD along
with a b-gal reporter construct to identify transfected cells. Cells were stimulated with insulin (10 mg/ml) for 10 min, then exposed briefly
to detergent to remove insoluble actin-myosin, fixed, and costained for actin and myosin IIB under conditions that preserve the associ-
ation of these protein in cells as described in Materials and Methods (Cramer and Mitchison, 1995). Immunofluorescent laser confocal
imaging was performed as described in Materials and Methods. Rhodamine-phalloidin (red) was used to visualize F-actin, whereas rab-
bit anti-myosin IIB and secondary FITC-conjugated goat anti–rabbit specific antibodies were used to visualize myosin (green). Yellow
staining is the colocalization of red and green staining in the merged image. An asterisk indicates transfected cells as detected by immu-
nostaining with a mouse anti-b-galactosidase antibody and a secondary antibody conjugated with Cy5 (blue, not shown). Arrowhead
shows actin-containing membrane ruffles. (C) COS-7 cells transfected with mutationally activated MEK and/or CAS-SD along with a
b-gal reporter construct to identify transfected cells and examined for actin-myosin association as described above. In some cases,
MEK1 transfected cells were exposed to 25 mM PD98059 for 2 h to block MEK activation of ERK before staining for actin and myosin.
Photomicrographs were taken with a Bio-Rad Labs 1024 laser and Zeiss Axiovert microscope (6003). An asterisk indicates transfected
cells and arrow shows membrane ruffles. (D) Insoluble myosin content of COS-7 cells treated as described in B and C. Cells were
stained with anti-myosin IIB and FITC-conjugated secondary antibodies and the total amount of green fluorescence intensity (3106)
determined per cell area (mm2) as described in Materials and Methods. Each bar represents the mean 6 SEM of 30–40 cells of 6–8 dif-
ferent fields of three independent experiments. Bars: (B and C) 10 mm. 
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traction (Fig. 6 A). In fact, the time necessary to achieve
half-maximal contraction was increased from 16 min in
control cells to 36 min in cells exposed to the MEK inhibi-
tor. Similar findings were obtained when cells were trans-
fected with the ERK phosphatase MKP-2 which blocks
ERK activity (data not shown). The time for half-maximal
contraction was also significantly increased in cells ex-
posed to the MLCK inhibitor M7 or in cells transfected
with a dominant negative form of MLCK (MLCK
 
2
 
) (Fig.
6, A and B), which prevents ERK-induced cell migration
and myosin light chain phosphorylation (Klemke et al.,
1997). In this case, half-maximal contraction time was in-
creased to 76 and 48 min in M7 and MLCK
 
2
 
 cells, respec-
tively, whereas control cells responded within 16 min. The
difference in cell contraction between M7 and those trans-
fected with MLCK
 
2
 
 is likely due to the fact that 
 
z
 
75% of
transfected cells express the MLCK
 
2
 
 construct, whereas
100% of the cells are exposed to M7. In support of these
results, cells exposed to BDM, a general inhibitor of
myosin ATPase activity (Cramer and Mitchison, 1995),
showed minimal contraction indicating that myosin plays a
central role in this process (Fig. 6). In contrast, contraction
was not altered in cells transfected with CAS-SD (Fig. 6 B)
which blocks membrane ruffling, but not actin-myosin
colocalization (Figs. 4 and 5). Similar findings were ob-
served when cells were transfected with Crk-SH2 (data
not shown). Importantly, the inhibition of cell contraction
induced by these compounds was not due to nonspecific
cell toxicity since their effect was reversed when they were
removed from the culture media (Fig. 6 C). Together,
these findings support the notion that ERK activation rep-
resents a distinct signaling pathway involved in the reg-
ulation of actin-myosin assembly and cell contraction,
whereas CAS/Crk coupling represents an independent
pathway that regulates actin membrane ruffling in migra-
tory cells. However, while inhibition of ERK or MLCK ac-
tivity decreased cell contraction, it did not completely
block this event, suggesting that additional signals may ex-
ist to regulate MLC phosphorylation and actin-myosin
 
contraction. Consistent with this possibility, Rho kinase is
known to promote MLC phosphorylation independent of
MLCK activity (Yoshioka et al., 1998).
 
Discussion
 
ERK activation and the molecular coupling of CAS and
Crk are initiated upon cell adhesion to ECM proteins
and/or exposure to various growth factors. Our findings
that formation of a CAS/Crk complex and activation of
the GTPase Rac are necessary for membrane ruffling,
whereas ERK activity is involved in actin-myosin contrac-
tion, suggest that these signaling events regulate specific
components of the migration/contraction machinery. Dur-
ing wound healing, the actin-myosin motor generates con-
tractile force necessary for both cell migration as well as
contraction of fibrin or collagen matrices. These cellular
events appear to be independently regulated of CAS/Crk
and Rac-associated events, while ERK regulates force
generation and cell contraction.
Several lines of evidence suggest that CAS/Crk and
ERK activation operate as components of separate signal-
ing pathways necessary for cell migration. First, dominant
negative forms of CAS and Crk that prevent CAS/Crk
coupling blocked cytokine-induced cell migration without
impacting ERK activation. Furthermore, inhibition of ERK
activation prevented cytokine-induced cell migration with-
out impacting CAS tyrosine phosphorylation or the for-
mation of a CAS/Crk complex. Second, while formation of
a CAS/Crk complex was sufficient to induce cell migration
in serum-starved cells, it failed to promote ERK activation,
indicating that this migration response was not the result
of increased ERK activity. However, ERK activity was
found to be a separate response necessary for CAS/Crk-
induced cell migration since blocking endogenous ERK
activity with PD98059 prevented CAS/Crk induced cell
migration, but had no effect on the coupling of these pro-
teins. In addition, we have observed that expression of
mutationally activated MEK in cells, while sufficient to in-
Figure 6. ERK activity, but not CAS/Crk association, is necessary for cell contraction of collagen gels. Three-dimensional collagen gels
containing COS-7 cells were released from the culture dish and allowed to contract for various times as described in Materials and
Methods. (A) COS-7 cells in collagen gels pretreated for 60 min with the MEK inhibitor PD98059 (50 mM), the MLCK inhibitor M7 (1
mM), or an inhibitor of myosin ATPase activity (BDM, 10 mM). (B) COS-7 cells transfected with either the empty expression vector
(control) or the vector containing CAS without a substrate domain (CAS-SD) or a dominant negative form of MLCK (MLCK2)
(Klemke et al., 1997). Contraction is presented as change in diameter (starting-final) measured in millimeters. (C) Cells treated as de-
scribed in A were washed to remove inhibitors then cultured an additional 24 h before being allowed to contract the collagen matrix for
various times as described in Materials and Methods. Each point represents the mean 6 SEM of three independent experiments. 
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duce ERK activation and cell migration, did not impact
CAS/Crk coupling (data not shown). That dominant nega-
tive forms of CAS and Crk were able to block MEK-
induced cell migration, but not ERK activation, provided
additional evidence that CAS/Crk and ERK are separate
events required for cell migration. Finally, CAS/Crk and
ERK represent distinct signals capable of regulating mem-
brane ruffling and contraction in migratory cells. That Ras
effector mutants deficient in their ability to facilitate ERK
activity retain the capacity to promote membrane ruffling
further support this notion (Joneson et al., 1996).
Our findings that CAS/Crk coupling was sufficient to in-
duce membrane ruffles suggests that at least one impor-
tant consequence of the molecular coupling of these pro-
teins in cells is to facilitate Rac activation and/or its
localization to the cell membrane. In fact, recent evidence
indicates that CAS/Crk coupling in cells can potentiate
Rac activity and cell spreading (Kiyokawa et al., 1998a).
This was found to depend on the recently described Rac-
activating protein DOCK180, which binds to the amino-
terminal SH3 domain of Crk (Kiyokawa et al., 1998a). Our
findings indicate that DOCK180 can potentiate CAS/Crk-
induced cell migration, an event that depends on Rac ac-
tivity. Together, these findings suggest that DOCK180 is
an important downstream mediator in the CAS/Crk motil-
ity response. Interestingly, cellular expression of farnesy-
lated, but not wild-type DOCK180, induced cell spreading
and ruffling (Kiyokawa et al., 1998a), suggesting that
DOCK180 requires localization to the cell surface to fully
activate Rac and the associated changes in the actin cy-
toskeleton. During cell migration, CAS/Crk may serve to
target DOCK180 to the membrane where it can interact
with Rac. Indeed, CAS/Crk and Rac are known to localize
to membrane ruffles of migratory cells (Tapon and Hall,
1997; Klemke et al., 1998). Alternatively, the association
of DOCK180 with CAS/Crk complexes may regulate
signaling from integrin adhesion receptors as recently
suggested (Kiyokawa et al., 1998b). In either case, this
appears to be independent of ERK signaling as cells
expressing CAS/Crk/DOCK180 complexes showed en-
hanced cell migration without significant changes in ERK
activity (Fig. 4 D). The ability of CAS/Crk complexes to
couple to DOCK180 may have important implications for
cell migration associated with development and cell me-
tastasis. The DOCK180 homologues, mbc and ced-5, iso-
lated from 
 
Drosophila melanogaster 
 
and 
 
Caenorhabditis ele-
gans
 
, respectively, play a role in cell motility associated with
the development of these organisms (Erickson et al., 1997;
Wu and Horvitz, 1998). In contrast, CAS/Crk coupling may
contribute to the migratory/invasive behavior of tumor cells
through its ability to couple to the Rac and PI3 kinase sig-
naling pathway (Keely et al., 1998). Indeed, carcinoma cells
that showed increased invasive and metastatic potential in
vivo were found to have increased CAS/Crk complexes
compared with non-metastatic cells (Klemke et al., 1998).
While it is not yet clear how ERK is regulated in migra-
tory cells, our findings indicate that CAS and Crk do not
play a central role in this signaling cascade. Recent evi-
dence suggests that several signals exist to regulate ERK
activity independent of CAS and Crk (reviewed by Aplin
et al., 1998; Schlaepfer et al., 1999). It is known that Src
can phosphorylate FAK at tyrosine 925 leading to a Grb2/
SOS association and direct ERK activation (Schlaepfer et
al., 1994). Furthermore, the FAK-related tyrosine kinase
Pyk2 directly couples integrin signals to ERK activation
independent of CAS/Crk coupling (Blaukat et al., 1999).
Protein kinase C and Grb2 binding to Shc provide ad-
ditional pathways capable of regulating ERK activity in
response to integrin events (Wary et al., 1996; Schlaepfer
et al., 1998). Alternatively, CAS-dependent mechanisms
may exist to link integrin and cytokine receptors to the
RAS/ERK pathway. For example, Nck couples to SOS as
well as tyrosine phosphorylated CAS. This could serve as
an alternate pathway to facilitate a low level of ERK activ-
ity in some cells (Schlaepfer et al., 1997). However, it is
not yet known if formation of a CAS/Nck complex is nec-
essary for ERK activation or cell migration.
Assembly of an actin-myosin motor unit is critical for
cell-mediated contraction of the ECM as well as cell
movement, suggesting that these processes may be related.
In fact, contraction of a collagen matrix involves a rapid
smooth muscle–like contraction that is associated with in-
creased ERK activity and myosin light chain phosphoryla-
tion (Grinnell, 1994; Rosenfeldt et al., 1998). Migratory
cells also assemble actin-myosin motors and exert force on
the ECM (Lauffenburger and Horwitz, 1996). This is
thought to generate the force necessary for the rapid re-
traction of the tail region that is known to occur in migra-
tory cells. Previous work has shown that ERK can directly
phosphorylate and, thereby, activate MLCK leading to
MLC phosphorylation (Klemke et al., 1997). In this re-
port, we have extended these findings by showing that
ERK activation can promote assembly of a functional ac-
tin-myosin motor unit capable of promoting cell contrac-
tion. Based on these findings, we propose that during cell
migration ERK facilitates MLCK activity and MLC phos-
phorylation leading to the assembly of actin-myosin mo-
tors, an event necessary for cell contraction, but not mem-
brane ruffling. On the other hand, CAS/Crk coupling
independently regulates Rac activity and membrane ruf-
fling in migratory cells. It is likely that additional signals
operate to control cytoskeletal changes involved in cell
movement. In fact, Rho modulates cell migration through
its ability to inactivate myosin phosphatase leading to in-
creased myosin light chain phosphorylation and cell con-
tractility (Yoshioka et al., 1998). Furthermore, v-Crk can
regulate Rho activity, suggesting that in some cells Crk
may be able to facilitate myosin contractility (Altun-Glu-
tekin et al., 1998). p21-activated kinase (Pak1) also regu-
lates MLC phosphorylation and cell motility in fibroblasts
(Sells et al., 1999), and Ras/ERK regulates integrin affinity
and modulates adhesive contacts with the ECM, which is
important for cell migration (Hughes et al., 1997).
Our findings that assembly of a CAS/Crk complex
and Rac activation are necessary for membrane ruffling,
whereas ERK activity facilitates actin-myosin contraction,
indicate that these signals regulate specific components of
the migration machinery. These findings provide molecu-
lar insight as to how cellular recognition of growth factors
and adhesive proteins regulate the process of cell move-
ment during development, wound healing, and inflamma-
tion, as well as tumor cell dissemination.
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